Log in

Relevant bibliographies by topics / Coronary disease

Contents

Journal articles
Dissertations / Theses
Books
Book chapters
Conference papers
Reports

Academic literature on the topic 'Coronary disease'

Author: Grafiati

Published: 4 June 2021

Last updated: 30 July 2024

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Coronary disease.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Coronary disease"

1

Nurmamadovna, Ishankulova Nasiba. "Coronary Heart Disease." American Journal of Medical Sciences and Pharmaceutical Research 03, no. 02 (February 28, 2021): 31–36. http://dx.doi.org/10.37547/tajmspr/volume03issue02-04.

Full text

Abstract:

The article covers the etiology, pathogenesis, classification, diagnosis, clinical picture and treatment of coronary heart disease, provides a literature review. Cardiovascular disease (CVD) represents the leading cause of death among women as well as men. The number of deaths due to CVD in women are greater than in men. There are significant gender-related differences concerning CVD.

APA, Harvard, Vancouver, ISO, and other styles

2

Akgül, Engin. "A Secret Enemy of Patients with Coronary Artery Disease: Depression." International Journal of Medical Reviews and Case Reports 2, Reports in Surgery and Dermatolo (2018): 1. http://dx.doi.org/10.5455/ijmrcr.depression-in-coronary-artery-disease.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Shakhnoza, Iskandarova, and Amilova Asalya. "PREVENTION OF CORONARY HEART DISEASE." American Journal of Medical Sciences and Pharmaceutical Research 04, no. 04 (April 1, 2022): 19–21. http://dx.doi.org/10.37547/tajmspr/volume04issue04-05.

Full text

Abstract:

Primary prevention, based on healthy lifestyle habits that prevent the emergence of risk factors, is the preferred method of reducing cardiovascular risk. Reducing the prevalence of obesity is the most urgent task, and it is pleiotropic in that it affects blood pressure, lipid profile, glucose metabolism, inflammation, progression of atherothrombotic disease. Physical activity also improves several risk factors, with the added potential to lower heart rate.

APA, Harvard, Vancouver, ISO, and other styles

4

Ashem Laikangbam Shaini, Niketa. "Serum Testosterone Levels and Coronary Artery Disease." International Journal of Science and Research (IJSR) 12, no. 4 (April 5, 2023): 1807–11. http://dx.doi.org/10.21275/sr23428011625.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Windecker, S. "CORONARY DISEASE: Intervention in coronary artery disease." Heart 83, no. 4 (April 1, 2000): 481–90. http://dx.doi.org/10.1136/heart.83.4.481.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Sharma, Vinod. "Incidental Coronary Artery Disease on Routine CT Coronary Angiography –An evidence-based approach." Clinical Cardiovascular Research 2, no. 1 (March 1, 2023): 01–04. http://dx.doi.org/10.58489/2836-5917/005.

Full text

Abstract:

Atherosclerotic coronary artery disease is the leading cause of high morbidity and mortality across the globe [1]. Coronary CT angiography has emerged as a highly accurate non-invasive diagnostic modality for the diagnosis of atherosclerotic coronary artery disease [2]. Coronary CT angiography should be considered as an alternative to stress imaging technique for ruling out atherosclerotic coronary artery disease in patients with the lower range of intermediate pre-test probability for atherosclerotic stable coronary artery disease. However, coronary CT angiography is not recommended as a screening test in asymptomatic individuals without clinical suspicion of coronary artery disease. CT Coronary angiography has been performed routinely before many of the cardiac and non-cardiac procedures like TAVI, atrial fibrillation ablation prior to the organ transplantation. Many a times, advised by Family Physician or patients themselves for a routine screening for atherosclerotic coronary artery disease undergo CT coronary angiography. When incidental atherosclerotic coronary artery disease is found in such patients who do not have any typical or atypical symptom suggestive of coronary artery disease then question arises how to approach this patient as far as the risk estimation for future adverse cardiovascular event and prognostication is concerned. It also becomes imperative to decide the line of management for this patient. To answer these two pertinent questions, we need to understand the behavior and natural history of atherosclerosis & performance of CT coronary angiography in diagnosis and in predicting the prognosis of atherosclerotic disease.

APA, Harvard, Vancouver, ISO, and other styles

7

MD, Mohamed Abdelaal. "Prevalence of Significant Coronary Artery Disease in Rheumatic Heart Disease Patients Undergoing Preoperative Coronary Angiography, Tanta University Hospital Experience." Journal of Medical Science And clinical Research 05, no. 02 (February 3, 2017): 17338–42. http://dx.doi.org/10.18535/jmscr/v5i2.19.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Singh, Vinay. "Prevalence of Vitamin D Deficiency in Coronary Artery Disease Diabetic and Non Coronary Artery Disease Diabetic Patients in Northern India." Journal of Advanced Research in Medicine 05, no. 03 (July 12, 2018): 19–22. http://dx.doi.org/10.24321/2349.7181.201816.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Goldhaber, SamuelZ. "CORONARY DISEASE." Lancet 341, no. 8845 (March 1993): 599–600. http://dx.doi.org/10.1016/0140-6736(93)90357-m.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Sharp, David. "CORONARY DISEASE." Lancet 341, no. 8836 (January 1993): 27–28. http://dx.doi.org/10.1016/0140-6736(93)92493-d.

Full text

APA, Harvard, Vancouver, ISO, and other styles

More sources

Dissertations / Theses on the topic "Coronary disease"

1

Holt, Jim, and Gregg Mitchell. "Coronary Artery Disease KSA." Digital Commons @ East Tennessee State University, 2019. https://dc.etsu.edu/etsu-works/6457.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Lee, Chi-hang, and 李志恆. "Microvascular obstruction following percutaneous coronary interventionfor coronary artery disease." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2009. http://hub.hku.hk/bib/B43278723.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Lee, Chi-hang. "Microvascular obstruction following percutaneous coronary intervention for coronary artery disease." Click to view the E-thesis via HKUTO, 2009. http://sunzi.lib.hku.hk/hkuto/record/B43278723.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Brouilette, Scott Wayne. "Telomeres and coronary heart disease." Thesis, University of Leicester, 2004. http://hdl.handle.net/2381/29899.

Full text

Abstract:

Using mean telomere length as a marker of biological age, I show that: 1. Subjects with premature myocardial infarction (MI) have significantly shorter telomeres than age-sex matched, healthy, controls. The mean telomere length in MI subjects was similar to controls almost 11 years older. 2. Healthy young adult children of families with a strong history of premature MI have shorter telomeres than age matched children of families without such a history. 3. Shorter telomere lengths are associated with increase risk of subsequent CHD events in a prospective study. This analysis was carried out on samples collected in the West of Scotland Coronary Prevention Study (WOSCOPS). This randomised blinded trial was designated to examine the benefits of statin treatment on preventing CHD and showed a 30% reduction of events in those treated with pravastatin. Interestingly, my analysis showed that this benefit of statin is only seen in those subjects at higher risk of CHD based on their telomere length.;As the final part of the thesis I carried out a quantitative linkage trait (QTL) analysis in sib-pairs in an attempt to identify genetic loci regulating telomere length. I report the mapping of a major QTL on chromosome 12 that determines almost 50% of the inter-individual variation in mean telomere length.;These findings support a novel "telomere" hypothesis of CHD. They indicate that telomere biology is intimately linked to the genetic aetiology and pathogenesis of CHD. Specifically, the findings suggest that (i) those individuals born with shorter telomeres may be at increased risk of CHD (ii) rather than individual genes, a more global structural property of the genetic material may explain the familial basis of CHD (iii) variation in telomere length may explain, in part, the variable age of onset of CHD. The findings provide several new avenues for future research.

APA, Harvard, Vancouver, ISO, and other styles

5

Stancell-Smith, Gwendolyn Yvonne. "Women and Coronary Artery Disease." ScholarWorks, 2017. https://scholarworks.waldenu.edu/dissertations/3415.

Full text

Abstract:

Heart disease, including coronary artery disease, affects approximately 42 million women in the United States. Many of those affected are not aware they have the condition. Contributing to the problem is the fact that women are more likely than men to be misdiagnosed and undertreated for heart disease. Morbidity and mortality are high in women affected by heart disease, making the problem important to address. The purpose of this project was to understand the coronary artery or heart disease risk and the treatment for the condition provided for 31 participants at a cardiology service in the Northeast U.S. The project question focused on understanding how coronary artery disease manifest in women and the gender differences in treatment for men and women. A descriptive case design was used by gathering data from patient risk profiles and treatments. Participants were males and females aged between 30 and 80. Qualitative data were obtained through cardiology staff interviews and existing literature. The data were subjected to a content analysis to identify emergent themes. Findings indicated that the women experienced different cardiac symptoms to men, and these differences translated to misdiagnosis and resulting treatment ineffectiveness. This project contributes to social change through raising awareness of the gender differences in heart disease presentation so that providers can recognize and treat the condition effectively.

APA, Harvard, Vancouver, ISO, and other styles

6

Starkhammar, Johansson Carin. "Periodontitis and coronary artery disease : Studies on the association between periodontitis and coronary artery disease." Doctoral thesis, Linköpings universitet, Kardiologi, 2012. http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-86213.

Full text

Abstract:

Periodontitis and coronary artery disease (CAD) are highly prevalent in Sweden’s population; both diseases have complicated pathogeneses and clinical manifestations due to immune-system triggered inflammation. Research in recent years reported that inflammation is a significant active participant in many chronic diseases. The literature described a CAD-periodontitis association, but underlying mechanisms are not fully understood. It is important to acquire knowledge about how periodontitis might influence CAD, which is one of the major causes of illness and death in western countries. Because periodontitis can be treated, this knowledge, when complemented with more knowledge about the CAD-periodontitis association, could lead to CAD prevention. The overall aim of studies reported in this thesis were to investigate the CAD-periodontitis association, and specifically, to: (i) compare periodontal conditions in patients with CAD and subjects without a history of CAD; (ii) study whether or not periodontal status influences outcomes in known CAD over an 8-year period; (iii) study whether or not concentrations and biological activity of hepatocyte growth factor (HGF) in serum from patients with severe CAD are different – depending on whether or not the subjects had periodontitis; and (iv) study concentrations and biological activity of hepatocyte growth factor in serum, saliva, and gingival crevicular fluid in healthy subjects with or without periodontitis. Here is a brief summary: In study I, 161 patients with CAD and 162 controls were compared regarding periodontal disease prevalence and severity. CAD patients had significant coronary stenosis and underwent percutaneous coronary intervention (PCI) or coronary artery by-pass grafts (CABG). Healthy controls were recruited from Sweden’s population database. Twenty-five per cent of the CAD patients had severe periodontitis, compared to 8% of the controls. In a multiple logistic regression analysis (controlled for age and smoking), severe periodontitis indicated an odds ratio of 5.74 (2.07–15.90) for CAD. Study II: Periodontal status was re-examined in 126 CAD patients and 121 controls from the initial sample after 8 years. Periodontal status at baseline was analysed and related to CAD endpoints (i.e., myocardial infarction, new PCI or CABG or death due to CAD) recorded from patients’ medical records and from the death index maintained by the National Board of Health and Welfare. The difference in periodontitis prevalence and severity between the two groups remained unchanged during the 8-year follow up. No significant differences were found regarding CAD endpoints during follow-up in relation to baseline periodontal status in the CAD-patient group. In study III, higher HGF serum concentrations (p<0.001) were found in CAD patients, compared to healthy blood donors, which reflects chronic inflammation. In CAD patients without periodontitis, HGF concentrations increased significantly 24 hours after PCI – in parallel with increased HGF biological activity. In CAD patients with periodontitis, only small fluctuations were seen in HGF values, i.e., concentration and biological activity. HGF biological activity was temporarily elevated after PCI but only in patients without periodontitis. Thus chronic inflammation related to periodontitis might reduce HGF biological activity. In study IV, HGF concentration and biological activity in saliva, in gingival crevicular fluid (GCF), and serum were compared between 30 generally healthy subjects with severe untreated periodontitis and 30 healthy subjects without periodontitis. Compared to periodontally healthy controls, periodontal patients showed higher HGF concentrations in saliva p<0.001, gingival crevicular fluid p<0.0001, and in serum p<0.001. HGF biological activity (measured as the binding affinity to its HSPG and c-MET receptors) was significantly reduced in saliva (p<0.0001) and GCF samples (p<0.0001 for HSPG and p<0.01 for c-MET) from periodontitis patients. The only significant difference in serum samples was an increases in c-MET binding three minutes after subgingival debridement in periodontitis patients (p<0.05), which might reflect that patients had active bursts of periodontitis. In conclusion, CAD patients more often showed severe periodontitis but there were no differences in CAD endpoints during the eight-year follow-up in relation to baseline periodontal status. Periodontitis seems to influence HGF concentration and biological activity in CAD patients, but studies on factors that cause lower HGF biological activity are necessary – to find out if periodontal treatment influences HGF biological activity. Healthy periodontitis patients had higher HGF concentrations locally and systemically, but biological activity was reduced. This might indicate that periodontitis can influence wound healing and tissue repair in other body parts.

The ISBN 987‐91‐7519‐748‐7 is incorrect. Correct ISBN is 978‐91‐7519‐748‐7.

APA, Harvard, Vancouver, ISO, and other styles

7

Heiser, Claire Anne. "Personality predictors of coronary heart disease." Thesis, Virginia Polytechnic Institute and State University, 1985. http://hdl.handle.net/10919/50027.

Full text

Abstract:

Fifty percent of the diagnosed cases of coronary heart disease in the United States are of unknown etiology. This study proposed that five personality traits— achievement, dominance, aggression, succorance and Critical Parent—differentiate individuals with coronary heart disease manifestations. The ultimate goal of this research was to formulate a predictive profile of at-risk individuals of developing coronary heart disease. Cardiac rehabilitation units' participants from across the United States were recruited as subjects. Randomly selected cardiac rehabilitation units were sent an initial letter inquiring whether their staff would be willing to participate in the study by administering the instruments to their participants. Eight units from each of the 50 states were contacted. A total of fourteen units agreed to participate. One hundred sixty-nine subjects completed the Demographic Data Questionnaire and the Adjective Check List. Five scale scores, representing the five personality differentials, were analyzed. Comparison of the male subject population (n=135) and the male normative population (n=198) revealed no significant differences in terms of the five traits. Comparison of diagnostic subgroups of the subject population also revealed no significant differences. It was concluded that the subject population did not differ significantly from the normative population in terms of the five traits assess by the instrument used. The goal of a predictive profile was not realized due to this lack of findings.
Master of Science
incomplete_metadata

APA, Harvard, Vancouver, ISO, and other styles

8

Rose, Edward Leslie. "Coronary heart disease in patients with peripheral vascular disease." Thesis, University of Oxford, 1991. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.305544.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Jensen, Jens. "On-line vectorcardiography during coronary angioplasty and unstable coronary artery disease /." Stockholm, 2000. http://diss.kib.ki.se/2000/91-628-4357-5/.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Danesh, John. "Chronic infection and coronary heart disease." Thesis, University of Oxford, 1999. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.326020.

Full text

APA, Harvard, Vancouver, ISO, and other styles

More sources

Books on the topic "Coronary disease"

1

National Heart, Lung, andlood Institute, ed. Coronary heart disease. [Bethesda, Md.?]: U.S. Dept. of Health and Human Services, National Institutes of Health, National Heart, Lung, and Blood Institute, 2003.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

2

Vlodaver, Zeev, Robert F. Wilson, and Daniel J. Garry, eds. Coronary Heart Disease. Boston, MA: Springer US, 2012. http://dx.doi.org/10.1007/978-1-4614-1475-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Willerson, James T., and David R. Holmes,, eds. Coronary Artery Disease. London: Springer London, 2015. http://dx.doi.org/10.1007/978-1-4471-2828-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Barsness, Gregory W., and David R. Holmes, eds. Coronary Artery Disease. London: Springer London, 2012. http://dx.doi.org/10.1007/978-1-84628-712-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Sandler, Gerald, ed. Coronary Heart Disease. Dordrecht: Springer Netherlands, 1986. http://dx.doi.org/10.1007/978-94-010-9218-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Scottish Forum for Public Health Medicine., Scottish Needs Assessment Programme, and Special Needs Action Programme, eds. Coronary heart disease. Glasgow: Scottish Forum for Public Health Medicine, 1998.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

7

National Board for Nursing, Midwifery and Health Visiting for Scotland. Coronary heart disease. Edinburgh: The Board, 1998.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

8

National Dairy Council. Nutrition Service. Coronary heart disease. London: National Dairy Council, 1993.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

9

Royal Colleges of Physicians of the United Kingdom. Committee on Health Promotion. Coronary heart disease. London: Faculty of Community Medicine of the Royal Colleges of Physicians of the United Kingdom, 1988.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

10

Anne, Halliday, Ashwell Margaret, and British Nutrition Foundation, eds. Coronary heart disease. London: British Nutrition Foundation, 1992.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

More sources

Book chapters on the topic "Coronary disease"

1

Pappworth, Maurice H. "Coronary Disease." In When Doctors Get Sick, 7–17. Boston, MA: Springer US, 1988. http://dx.doi.org/10.1007/978-1-4899-2001-0_2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Roth, Elliot J. "Coronary Disease." In Encyclopedia of Clinical Neuropsychology, 965–66. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-57111-9_2172.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Roth, Elliot J. "Coronary Disease." In Encyclopedia of Clinical Neuropsychology, 708. New York, NY: Springer New York, 2011. http://dx.doi.org/10.1007/978-0-387-79948-3_2172.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Roth, Elliot J. "Coronary Disease." In Encyclopedia of Clinical Neuropsychology, 1–2. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-56782-2_2172-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Newburger, Jane W., and Hirohisa Kato. "Kawasaki Disease." In Coronary Artery Disease, 581–95. London: Springer London, 2015. http://dx.doi.org/10.1007/978-1-4471-2828-1_22.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Bergersen, Lisa, Susan Foerster, Audrey C. Marshall, and Jeffery Meadows. "Coronary Angiography." In Congenital Heart Disease, 143–50. Boston, MA: Springer US, 2009. http://dx.doi.org/10.1007/978-0-387-77292-9_23.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Wilson, Robert F. "Coronary Angiography." In Coronary Artery Disease, 69–144. London: Springer London, 2015. http://dx.doi.org/10.1007/978-1-4471-2828-1_5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Theisler, Charles. "Coronary Heart Disease/Coronary Artery Disease (CAD)/Ischemic Heart Disease/Coronary Atherosclerosis." In Adjuvant Medical Care, 78–80. New York: CRC Press, 2022. http://dx.doi.org/10.1201/b22898-92.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Smuclovisky, Claudio. "Coronary Artery Disease." In Coronary Artery CTA, 33–67. New York, NY: Springer New York, 2009. http://dx.doi.org/10.1007/978-1-4419-0431-7_3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Valantine, H. A., and J. S. Schroeder. "Transplant Coronary Disease." In Heart Failure Mechanisms and Management, 466–74. Berlin, Heidelberg: Springer Berlin Heidelberg, 1991. http://dx.doi.org/10.1007/978-3-642-58231-8_50.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Coronary disease"

1

Finn, Ronan, Tim McGloughlin, Patrick Delassus, and Liam Morris. "Deformations During and Post Stenting of a Diseased Coronary Artery Phantom: An In Vitro Study." In ASME 2009 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2009. http://dx.doi.org/10.1115/sbc2009-206655.

Full text

Abstract:

World-wide, deaths from cardiovascular diseases exceed those caused by cancer, infectious disease and trauma [1]. Coronary stenting is an established treatment for patients with symptomatic coronary artery disease. Although stents reduce restenosis rates in carefully selected lesions, in-stent restenosis remains a recognized clinical problem. Restenosis, defined as “the arterial healing response after injury during transluminal coronary revascularisation” [2], has been the principal drawback of coronary stenting since its conception nearly 30 years ago [3]. While there have been many studies on the short and long term effects of coronary artery stenting, less is known of the injury caused by the balloon and stent during the stenting process. The objective of this study is to fabricate compliant and morphologically realistic models of the right coronary artery (RCA) for preclinical bench-top testing of intraluminal stents, in diseased cases.

APA, Harvard, Vancouver, ISO, and other styles

2

Freitas, Samuel A., Cristiano A. da Costa, and Gabriel De O. Ramos. "Coronary Artery Disease Automatic Classification." In Escola Regional de Computação Aplicada à Saúde. Sociedade Brasileira de Computação - SBC, 2021. http://dx.doi.org/10.5753/ercas.2021.17431.

Full text

Abstract:

Atherosclerosis represents the restriction of blood ﬂow in the heart muscle and is one of the main causes of death in the world. The assessment of atherosclerosis is challenging and is currently evaluated by the Fractional Flow Reserve (FFR) and the Quantitative Flow Ratio (QFR). Both exams are based on angiography, which is the gold standard for geometrical assessment. This study presents a pipeline to automatically determine the presence of narrowing in the right coronary artery (RCA) angiography exams, segmenting the artery silhouette, selecting regions of interest (ROIs) followed by a classification model. Initial results suggest a valid sequence of steps to classify the lesion, but require some improvements in the network architecture for better classification accuracy.

APA, Harvard, Vancouver, ISO, and other styles

3

Paradkar, Neeraj, and Shubhajit Roy Chowdhury. "Coronary artery disease detection using photoplethysmography." In 2017 39th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC). IEEE, 2017. http://dx.doi.org/10.1109/embc.2017.8036772.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Banerjee, Rohan, Ramu Vempada, K. M. Mandana, Anirban Dutta Choudhury, and Arpan Pal. "Identifying coronary artery disease from photoplethysmogram." In UbiComp '16: The 2016 ACM International Joint Conference on Pervasive and Ubiquitous Computing. New York, NY, USA: ACM, 2016. http://dx.doi.org/10.1145/2968219.2972712.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Nassif, Ali Bou, Omar Mahdi, Qassim Nasir, Manar Abu Talib, and Mohammad Azzeh. "Machine Learning Classifications of Coronary Artery Disease." In 2018 International Joint Symposium on Artificial Intelligence and Natural Language Processing (iSAI-NLP). IEEE, 2018. http://dx.doi.org/10.1109/isai-nlp.2018.8692942.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Woodburn, Kathryn W., Shari L. Rodriquez, Atsushi Yamaguchi, Motoya Hayase, Robert C. Robbins, and David Kessel. "Motexafin lutetium in graft coronary artery disease." In BiOS 2000 The International Symposium on Biomedical Optics, edited by Thomas J. Dougherty. SPIE, 2000. http://dx.doi.org/10.1117/12.379878.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Banerjee, Shibabroto, Pourush Sood, Sujoy Ghose, and Partha Pratim Das. "Coronary Artery Disease Classification from Photoplethysmographic Signals." In ICMHI 2020: 2020 4th International Conference on Medical and Health Informatics. New York, NY, USA: ACM, 2020. http://dx.doi.org/10.1145/3418094.3418116.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Riyaz, Lubna, Muheet Ahmed Butt, and Majid Zaman. "Ensemble Learning for Coronary Heart Disease Prediction." In 2022 International Conference on Intelligent Technologies (CONIT). IEEE, 2022. http://dx.doi.org/10.1109/conit55038.2022.9848292.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Pareek, Vishakha, and R. K. Sharma. "Coronary heart disease detection from voice analysis." In 2016 IEEE Students' Conference on Electrical, Electronics and Computer Science (SCEECS). IEEE, 2016. http://dx.doi.org/10.1109/sceecs.2016.7509344.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

MacLeod, Mairi, Aaron Braddy-Green, Ralph Lopez, Philippa Webb, Logan Sun, Paras Dalal, Kristopher Knott, et al. "Coronary artery disease, COPD exacerbation and inflammation." In ERS International Congress 2023 abstracts. European Respiratory Society, 2023. http://dx.doi.org/10.1183/13993003.congress-2023.pa1334.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Coronary disease"

1

Sun, Jing-Chao, and Xuan-Yan Liu. Intravascular imaging or physiology-guided coronary revascularization in patients with multivessel coronary disease. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, February 2024. http://dx.doi.org/10.37766/inplasy2024.2.0092.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Zhang, Ruizhe, and Qingya Xie. A meta-analysis of cholesteryl ester transfer protein(CETP) gene rs708272(G>A) polymorphism in association with cornoary heart disease risk. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, June 2023. http://dx.doi.org/10.37766/inplasy2023.6.0021.

Full text

Abstract:

Review question / Objective: To seek the association of the CETP rs708272 polymorphism with CHD.To figure out if the carriers of allele rs708272-A reduce or increase the risk of CHD in comparison with carriers of allele rs708272-G under allele model, dominant model and recessive model. Condition being studied: The inclusion criteria of CHD:(1)the presence of stenosis≥50% in a minimum of one main segment of coronary arteries (the right coronary artery, left circumfex, or left anterior descending arteries) by coronary angiography.(2) symptoms representing angina pectoris, electrocardiographic changes, and elevations of cardiac enzymes based on the criteria of the World Health Organization. (3) a certifed record of coronary artery bypass graft or percutaneous coronary intervention were included in the study.The exclusion criteria of CHD :patients with congenital heart disease, cardiomyopathy, and valvular disease.Controls:the same populations as the cases and specifed to be without CAD, cardiovascular and cerebrovascular diseases, and peripheral atherosclerotic arterial disease.

APA, Harvard, Vancouver, ISO, and other styles

3

Banning, Adrian P., and Giovanni Luigi De Maria. Use of Intravascular Ultrasound Imaging in Percutaneous Coronary Intervention on Left Main Coronary Artery Disease. Radcliffe Cardiology, November 2017. http://dx.doi.org/10.15420/rc.2017.m004.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Wei, Dongmei, Yang Sun, and Hankang Hen. Effects of Baduanjin exercise on cardiac rehabilitation after percutaneous coronary intervention: A protocol for systematic review and meta-analysis of randomized controlled trials. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, April 2022. http://dx.doi.org/10.37766/inplasy2022.4.0080.

Full text

Abstract:

Review question / Objective: Can Baduanjin exercise improve the cardiac rehabilitation of patients with coronary artery disease after percutaneous coronary artery surgery? Condition being studied: Coronary heart disease (CHD), also known as coronary artery disease (CAD), is the single most common cause of death globally, with 7.4 million deaths in 2013, accounting for one-third of all deaths (WHO 2014). PCI has been shown to be effective in reducing mortality in patients with CHD. During follow-up, it has been shown that the benefits of PCI can be offset by the significant risks of coronary spasm, endothelial cell injury, recurrent ischemia, and even restenosis or thrombus. Numerous guidelines endorse the necessity for cardiac rehabilitation (CR), which is recommended for patients with chronic stable angina, acute coronary syndrome and for patients following PCI. Baduanjin have been widely practised in China for centuries, and as they are considered to be low risk interventions, their use for the prevention of cardiovascular disease is now becoming more widespread. The ability of Baduanjin to promote clinically meaningful influences in patients with CHD after PCI, however, still remains unclear.

APA, Harvard, Vancouver, ISO, and other styles

5

Sun, Jing-Chao, and Xuan-Yan Liu. Comparison of immediate and staged complete revascularization in patients with acute coronary syndrome and multivessel coronary disease. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, August 2023. http://dx.doi.org/10.37766/inplasy2023.8.0112.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Weng, JIeqiong, Jingfang Zhang, Ke Xu, Mengfei Yuan, Tingting Yao, Xinyu Wang, and Xiaoxu Shen. Efficacy of Shexiang Baoxin Pills Combined with Statins on Blood Lipid Profile in Patients with Coronary Heart Disease: A systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, September 2022. http://dx.doi.org/10.37766/inplasy2022.9.0100.

Full text

Abstract:

Review question / Objective: P（Population) ：Patients with coronary heart disease; I（Intervention) : Statins treatment in combination with Shexiang Baoxin pill; C（Comparison): Statins alone; O（Outcome）: Improvement of symptoms and blood lipids; S（Study design）：Clinical randomized trials. Eligibility criteria: To be included, trials were required to meet the following criteria: (1) patients were included in the studies according to diagnostic criteria of coronary heart disease established by the WHO, InternationalSociety of Cardiology and Association (ISCA), Internal Medicine, 7th edition ( IM-7th), Practice of InternalMedicine, 14th edition ( PIM-14th), Guidelines for the Diagnosis of Cardiovascular Diseases in InternalMedicine, 3rd edition (GIM-3rd) or conventional diagnostic criteria (CDC) including assessment of anginapectoris and electrocardiogram (ECG) results; (2) the study was conducted as a randomized controlled trial.

APA, Harvard, Vancouver, ISO, and other styles

7

Karamfiloff, Kiril, Lili Vladimirova, Dobrin Vassilev, and Milena Staneva. Noninfarct-related Coronary Artery Disease and Early Mortality among Patients with ST-elevation Myocardial Infarction Treated with Primary Percutaneous Coronary Intervention. "Prof. Marin Drinov" Publishing House of Bulgarian Academy of Sciences, April 2019. http://dx.doi.org/10.7546/crabs.2019.04.16.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Wang, Shuang, Aidong Liu, Zhilei Wang, and Yue Zhang. Efficacy and safety of acupuncture combined with Chinese herbal medicine in the treatment of angina pectoris of coronary heart disease: a systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, November 2021. http://dx.doi.org/10.37766/inplasy2021.11.0100.

Full text

Abstract:

Review question / Objective: This study is the protocol for a systematic review to evaluate the Efficacy and safety of acupuncture combined with Chinese herbal medicine in the treatment of angina pectoris of coronary heart disease: a systematic review and meta-analysis. we conducted a systematic review and meta-analysis of published randomized clinical trials (RCTs) of such combined therapy in the treatment of angina pectoris of coronary heart disease, It provides a reliable scientific basis for clinicians to use this approach to treat angina pectoris of coronary heart disease. Information sources: We conducted a systematic search for relevant documents in the Chinese and English databases, and the search time is limited to November 23, 2021. The following eight databases are included : PubMed,EMBASE, Web of Science, The Cochrane Library, Chinese Biomedical Literature Database (CBM), Chinese National Knowledge Infrastructure (CNKI), Chinese Science and Technology Periodical Database (VIP), Wanfang Database.Relevant journals were searched to trace the references included in the study. Other resources will be searched if necessary.

APA, Harvard, Vancouver, ISO, and other styles

9

McCausland, Rachel, Joann Fontanarosa, and Ravi Patel. Nonemergent Percutaneous Coronary Intervention Versus Optimal Medical Treatment for Stable Ischemic Heart Disease: A Rapid Response Literature Review. Agency for Healthcare Research and Quality (AHRQ), August 2023. http://dx.doi.org/10.23970/ahrqepcrapidcoronary.

Full text

Abstract:

Aims. There is uncertainty around the optimal role of percutaneous coronary intervention (PCI) for management of chronic coronary syndrome, specifically when patients have disease in multiple coronary vessels and disease in the proximal portion of the left anterior descending coronary artery. This uncertainty was reflected in 2021 guidance from the American College of Cardiology (ACC)/American Heart Association (AHA) on coronary artery revascularization. The Agency for Healthcare Research and Quality has commissioned this rapid response literature review to meet a Congressional request for a summary of recent evidence on the benefits of angioplasties conducted in nonemergency situations. Methods. This rapid response literature review on the comparative effectiveness of nonemergent PCI followed established best systematic review methods, modified to meet a shortened project timeframe. We searched PubMed®, Embase®, and the Trip© medical database from 2018 through April 2023 for systematic reviews (SRs), clinical practice guidelines, and randomized controlled trials, and summarized the evidence comparing PCI to optimal medical therapy (OMT) for stable ischemic heart disease (SIHD). Our primary outcomes of interest were major objective cardiovascular outcomes, including mortality, myocardial infarction, stroke, urgent revascularization, or composites of one or more of these hard clinical outcomes. Where available, we also abstracted patient reported outcomes (e.g., angina severity and quality of life [QoL]) from included studies. Findings. Key findings from nine SRs and one primary study include: • The body of evidence directly comparing PCI to OMT for SIHD has remained largely unchanged since the 2021 ACC/AHA guidance’s publication. • Most studies of revascularization for coronary artery disease do not focus on direct head-to-head comparisons of PCI versus OMT for SIHD but instead either (1) compare OMT to invasive revascularization (PCI and coronary artery bypass graft [CABG] combined cohort); (2) compare PCI to CABG; or (3) compare different PCI techniques. • Another factor that complicates comparison is that the meta-analyses often included data from CABG and PCI combined cohorts (e.g., the recent landmark ISCHEMIA trial) but reported the outcomes as PCI specific. • In the general SIHD population, our review did not find evidence to support survival benefit or effect on hard clinical outcomes when PCI is added to OMT. • Limited evidence indicates there may be a beneficial effect of PCI on angina symptoms and measures of QoL, but most systematic reviews focused on major objective cardiovascular outcomes and did not consider QoL or freedom from angina. • Both OMT and PCI have evolved significantly during the period of time in which the systematic reviews’ included studies were conducted. It is not clear how these changes may have affected the applicability of past studies to current practice. Conclusions. The evidence directly comparing PCI to OMT for SIHD has remained largely unchanged since publication of the 2021 ACC/AHA guidelines. More research is needed to verify the comparative effectiveness of nonemergent PCI compared to medical treatment for individuals with SIHD, and how the effectiveness varies by certain patient populations and clinical presentation.

APA, Harvard, Vancouver, ISO, and other styles

10

Dong, Guoqi, Mengye Lu, Xiaoliang Wu, Hao Chen, Hongru Zhang, and Yihuang Gu. Network meta-analysis of Traditional Chinese medicines for depression in coronary heart disease patients. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, May 2020. http://dx.doi.org/10.37766/inplasy2020.5.0036.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!